NEW YORK — Dutch laboratory equipment supplier Bioké said last week that it has signed separate agreements to distribute Mission Bio's Tapestri single-cell multi-omics platform and LevitasBio's LeviCell cell separation system in the Netherlands, Belgium, and Luxembourg.
Additional terms of the deals were not disclosed.
Tapestri enables the simultaneous measurement of DNA and proteins in a single experiment and in single cells. San Francisco-based Mission Bio is primarily targeting its system toward clinical trial and drug development work, with a focus on cancer.
LeviCell uses magnet-induced density gradients to spread out different types of cells and requires no markers or modifications. Menlo Park, California-based LevitasBio, which was spun out of Stanford University, launched the platform last year.
Bioké, a business unit of Cell Signaling Technology Europe, has similar agreements with other firms. In mid-2019, for example, it signed on to distribute Parallex BioAssays' SnapChip microarray products in the Netherlands, Belgium, and Luxembourg.